VQ11 Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
14-16 weeks lead time (made-to-order)
Synonyms
VQ11 antibody; MVQ5 antibody; At1g80450 antibody; T21F11.22VQ motif-containing protein 11 antibody; AtVQ11 antibody; MPK3/6-targeted VQ-motif-containing protein 5 antibody
Target Names
VQ11
Uniprot No.

Target Background

Function
This antibody may modulate the activity of WRKY transcription factors.
Database Links

KEGG: ath:AT1G80450

STRING: 3702.AT1G80450.1

UniGene: At.33895

Subcellular Location
Nucleus.

Q&A

VQ11 Antibody Research FAQs

Advanced Research Challenges

  • How should conflicting data on VQ11 antibody cross-reactivity be resolved?

    MethodUse CaseLimitations
    Epitope binningMaps competing antibody binding sitesLimited to linear epitopes
    Cryo-EM structural analysisResolves conformational epitopesRequires high antigen purity
    Deep mutational scanningIdentifies critical binding residuesComputationally intensive
  • What strategies improve reproducibility of VQ11 antibody-dependent cellular phagocytosis (ADCP) assays?

    • Standardize effector cell sources (e.g., use cryopreserved primary monocytes) .

    • Include blocking controls with Fcγ receptor inhibitors to confirm antibody-Fc mediation .

    • Quantify phagocytosis via imaging flow cytometry (>5,000 events per sample) .

  • How can computational modeling predict VQ11 antibody-antigen binding modes?

    • Apply RosettaAntibody for docking simulations, constrained by HDX-MS (hydrogen-deuterium exchange) data .

    • Train machine learning models on phage display sequencing data to rank CDR3 loop conformations .

    • Validate predictions using alanine scanning mutagenesis (≥2.5-fold KD change = critical residue) .

Methodological Best Practices

  • What statistical approaches mitigate false positives in high-throughput VQ11 screens?

    • Use Benjamini-Hochberg correction for multiple comparisons (FDR <5%) .

    • Implement plate-wise normalization against internal controls (e.g., non-target IgG4) .

    • Employ Bayesian hierarchical models to account for batch effects in multi-site studies .

  • How to optimize VQ11 antibody labeling for multiplexed spatial proteomics?

    • Titrate metal-conjugated antibodies (1:50–1:200 dilution) using CODEX/IMC platforms .

    • Validate signal linearity across 3-log antigen concentration range .

    • Pre-treat tissues with light fixation (0.25% PFA) to preserve epitope accessibility .

Emerging Technical Frontiers

  • Can single-cell sequencing resolve clonal heterogeneity in VQ11 antibody responses?

    • Pair 10x Genomics V(D)J sequencing with CITE-seq for simultaneous epitope binding and transcriptome profiling .

    • Apply lineage tracing algorithms to reconstruct B-cell phylogenetic trees from somatic hypermutation patterns .

  • What CRISPR-based tools enable functional validation of VQ11 neutralizing capacity?

    • Use Cas9-ERT2 knock-in mice for conditional antigen knockout in challenge studies .

    • Develop lentiviral pseudotype neutralization assays with luciferase reporters (EC50 <100 ng/ml = potent) .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.